［1］Fam SY, Chee CF, Yong CY, et al. Stealth coating of nanoparticles in drugdelivery systems［J］. Nanomaterials(Basel), 2020, 10(4): 787.
［2］Sheikhpour M, Barani L, Kasaeian A. Biomimetics in drug delivery systems: a critical review［J］. J Control Release, 2017, 253: 97-109.
［3］Sabu C, Rejo C, Kotta S, et al. Bioinspired and biomimetic systems for advanced drug and gene delivery［J］. J Control Release, 2018, 287: 142-155.
［4］Jeanne A, Sarazin T, Charlé M, et al. Towards the therapeutic use of thrombospondin 1/CD47 targeting TAX2 peptide as an antithrombotic agent［J］. Arterioscler Thromb Vasc Biol, 2021, 41(1): e1-e17.
［5］Wang H, Liu Y, He R, et al. Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery［J］. Biomater Sci, 2020, 8(2): 552-568.
［6］Roweth HG, Battinelli EM. Lessons to learn from tumoreducated platelets［J］. Blood, 2021, 137(23): 3174-3180.
［7］Liu Y, Zhang Y, Ding Y, et al. Plateletmediated tumor metastasis mechanism and the role of cell adhesion molecules［J］. Crit Rev Oncol Hematol, 2021, 167: 103502.
［8］Le QV, Lee J, Lee H, et al. Cell membranederived vesicles for delivery of therapeutic agents［J］. Acta Pharm Sin B, 2021, 11(8): 2096-2113.
［9］Xu P, Zuo H, Chen B, et al. Doxorubicinloaded platelets as a smart drug delivery system: An improved therapy for lymphoma［J］. Sci Rep, 2017, 7: 42632.
［10］Lazar S, Goldfinger LE. Platelets and extracellular vesicles and their cross talk with cancer［J］. Blood, 2021, 137(23): 3192-3200.
［11］Chi C, Li F, Liu H, et al. Docetaxelloaded biomimetic nanoparticles for targeted lung cancer therapy in vivo［J］. J Nanopart Res, 2019, 21(7): 1-10.
［12］Wang H, Wu J, Williams GR, et al. Plateletmembranebiomimetic nanoparticles for targeted antitumor drug delivery［J］. J Nanobiotechnology, 2019, 17(1): 60.
［13］Li B, Chu T, Wei J, et al. Plateletmembranecoated nanoparticles enable vascular disrupting agent combining antiangiogenic drug for improved tumor vessel impairment［J］. Nano Lett, 2021, 21(6): 2588-2595.
［14］Chen Y, Zhao G, Wang S, et al. Plateletmembranecamouflaged bismuth sulfide nanorods for synergistic radiophotothermal therapy against cancer［J］. Biomater Sci, 2019, 7(8): 3450-3459.
［15］Ding K, Zheng C, Sun L, et al. NIR lightinduced tumor phototherapy using ICG delivery system based on plateletmembranecamouflaged hollow bismuth selenide nanoparticles［J］. Chin Chem Lett, 2020, 31(5): 1168-1172.
［16］Bahmani B, Gong H, Luk BT, et al. Intratumoral immunotherapy using plateletcloaked nanoparticles enhances antitumor immunity in solid tumors［J］. Nat Commun, 2021, 12(1): 1999.
［17］Jiang Q, Wang K, Zhang X, et al. Platelet membranecamouflaged magnetic nanoparticles for ferroptosisenhanced cancer immunotherapy［J］. Small, 2020, 16(22): e2001704.
［18］Zhuang J, Gong H, Zhou J, et al. Targeted gene silencing in vivo by platelet membranecoated metalorganic framework nanoparticles［J］. Sci Adv, 2020, 6(13): eaaz6108.
［19］Wang L, Tang C. Targeting platelet in atherosclerosis plaque formation: current knowledge and future perspectives［J］. Int J Mol Sci, 2020, 21(24): 9760.
［20］Song Y, Huang Z, Liu X, et al. Platelet membranecoated nanoparticlemediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein Edeficient (ApoE-/-) mice［J］. Nanomedicine, 2019, 15(1): 13-24.
［21］Ma Y, Ma Y, Gao M, et al. Plateletmimicking therapeutic system for noninvasive mitigation of the progression of atherosclerotic plaques［J］. Adv Sci(Weinh), 2021, 8(8): 2004128.
［22］Wang S, Wang R, Meng N, et al. Platelet membranefunctionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy［J］. J Control Release, 2020, 328: 78-86.
［23］Zhao Y, Xie R, Yodsanit N, et al. Hydrogen peroxideresponsive platelet membranecoated nanoparticles for thrombus therapy［J］. Biomater Sci, 2021, 9(7): 2696-2708.
［24］Chouchani ET, Pell VR, James AM, et al. A unifying mechanism for mitochondrial superoxide production during ischemiareperfusion injury［J］. Cell Metab, 2016, 23(2): 254-263.
［25］Tang J, Shen D, Caranasos TG, et al. Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome［J］. Nat Commun, 2017, 8: 13724.
［26］Su T, Huang K, Ma H, et al. Plateletinspired nanocells for targeted heart repair after ischemia/reperfusion injury［J］. Adv Funct Mater, 2019, 29(4): 1803567.
［27］Xu L, Chen Y, Jin Q, et al. Biomimetic PLGA microbubbles coated with platelet membranes for early detection of myocardial ischaemiareperfusion injury［J］. Mol Pharm, 2021, 18(8): 2974-2985.
［28］Kim JK, Uchiyama S, Gong H, et al. Engineered biomimetic platelet membranecoated nanoparticles block Staphylococcus aureus cytotoxicity and protect against lethal systemic infection［J］. Engineering, 2021, 7(8): 1149-1156.
［29］EstebanFernández de vila B, Angsantikul P, RamírezHerrera DE, et al. Hybrid biomembranefunctionalized nanorobots for concurrent removal of pathogenic bacteria and toxins［J］. Sci Robot, 2018, 3(18): eaat0485.
［30］He Y, Li R, Liang J, et al. Drug targeting through platelet membranecoated nanoparticles for the treatment of rheumatoid arthritis［J］. Nano Res, 2018, 11(11): 6086-6101.
［31］Wei X, Gao J, Fang RH, et al. Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia［J］. Biomaterials, 2016, 111: 116-123.
